Periconceptional folic acid use and the prevalence of positional plagiocephaly

Alice Michels1, Nadia El Bakkali, Caroline H Bastiaenen

  • 1Departments of Plastic & Reconstructive Surgery, Academic Hospital Maastricht, Ddebeyelaan 25, The Netherlands. Alicemichaels@yahoo.com

Insights

Increased folic acid (FA) supplementation, especially "double use," may be linked to a rise in positional plagiocephaly (PP) in infants. Further research is needed to confirm this potential adverse effect of high FA intake.

Area of Science:

  • Perinatal health
  • Pediatric developmental disorders
  • Nutritional science

Background:

  • Positional plagiocephaly (PP) incidence has risen in the Netherlands over two decades.
  • While back-sleeping advice is a primary suspect, other factors warrant investigation.
  • Folic acid (FA) supplementation recommendations also changed during this period.

Purpose of the Study:

  • To investigate the potential association between folic acid (FA) intake and the increased incidence of positional plagiocephaly (PP).
  • To evaluate if excessive FA supplementation, beyond recommended levels, correlates with PP development.

Main Methods:

  • Utilized data from the "Maastricht Cohort and Intervention study about pregnancy related girdlepain" (n=7526).
  • Prospectively collected data on folic acid (FA) intake from pregnant women.
  • Compared FA intake patterns between a control group and a group with children diagnosed with PP.

Main Results:

  • "Double use" of FA (isolated preparations plus multivitamins) was more frequent in the PP group (33.3%) compared to the control group (13.2%).
  • The PP group was too small for statistical analysis, but the trend suggests a potential link.
  • High FA intake, exceeding 1 mg daily through combined supplementation, was observed in some women.

Conclusions:

  • A potential empirical relationship exists between excessive folic acid (FA) "double use" and the occurrence of positional plagiocephaly (PP).
  • High FA intake may represent an adverse effect contributing to PP, warranting further investigation.
  • This study highlights the need for more extensive research into the safety of combined FA supplementation during pregnancy.

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Neurulation01:30

Neurulation

Neurulation is the embryological process which forms the precursors of the central nervous system and occurs after gastrulation has established the three primary cell layers of the embryo: ectoderm, mesoderm, and endoderm. In humans, the majority of this system is formed via primary neurulation, in which the central portion of the ectoderm—originally appearing as a flat sheet of cells—folds upwards and inwards, sealing off to form a hollow neural tube. As development proceeds, the anterior...